Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jianling Wang

Showing results (1-10 of 151) with videos related to

Pageof 16
Sort By:
Current Pharmaceutical Design|July 16, 2009
Comprehensive assessment of ADMET risks in drug discoveryJianling Wang
Acta Crystallographica. Section E, Structure Reports Online|May 19, 2011
(3,4-Dimeth-oxy-phen-yl)(4-fluoro-phen-yl)methanoneQuanjian Lv, Jianling Wang
Chemistry & Biodiversity|November 26, 2009
Recent advances in physicochemical and ADMET profiling in drug discoveryJianling Wang, Suzanne Skolnik
Environmental Science and Pollution Research International|December 6, 2019
Climate change, vulnerability, and its impacts in rural Pakistan: a reviewShah Fahad, Jianling Wang
Expert Opinion on Drug Metabolism & Toxicology|March 23, 2011
Maximizing the outcome of early ADMET models: strategies to win the drug-hunting battles?Jianling Wang, Alan Collis
Current Topics in Medicinal Chemistry|May 17, 2013
Permeability diagnosis model in drug discovery: a diagnostic tool to identify the most influencing properties for gastrointestinal permeabilityJianling Wang, Suzanne Skolnik
Expert Opinion on Drug Metabolism & Toxicology|January 13, 2010
Mitigating permeability-mediated risks in drug discoveryJianling Wang, Suzanne Skolnik
Expert Opinion on Drug Metabolism & Toxicology|June 12, 2012
Probe ADME and test hypotheses: a PATH beyond clearance in vitro-in vivo correlations in early drug discoveryLeslie C Bell, Jianling Wang
Journal of Pharmaceutical Sciences|February 11, 2012
Assessment of biliary clearance in early drug discovery using sandwich-cultured hepatocyte modelGuoyu Pan, Carri Boiselle, Jianling Wang
Journal of Cellular Biochemistry|March 16, 2019
miR-4458 regulates cell proliferation and apoptosis through targeting SOCS1 in triple-negative breast cancerXiaomeng Liu, Jianling Wang, Guochao Zhang
Pageof 16

Showing results (1-10 of 151) with videos related to

Sort By:
Pageof 16
Current Pharmaceutical Design|July 16, 2009
Comprehensive assessment of ADMET risks in drug discoveryJianling Wang
Acta Crystallographica. Section E, Structure Reports Online|May 19, 2011
(3,4-Dimeth-oxy-phen-yl)(4-fluoro-phen-yl)methanoneQuanjian Lv, Jianling Wang
Chemistry & Biodiversity|November 26, 2009
Recent advances in physicochemical and ADMET profiling in drug discoveryJianling Wang, Suzanne Skolnik
Environmental Science and Pollution Research International|December 6, 2019
Climate change, vulnerability, and its impacts in rural Pakistan: a reviewShah Fahad, Jianling Wang
Expert Opinion on Drug Metabolism & Toxicology|March 23, 2011
Maximizing the outcome of early ADMET models: strategies to win the drug-hunting battles?Jianling Wang, Alan Collis
Current Topics in Medicinal Chemistry|May 17, 2013
Permeability diagnosis model in drug discovery: a diagnostic tool to identify the most influencing properties for gastrointestinal permeabilityJianling Wang, Suzanne Skolnik
Expert Opinion on Drug Metabolism & Toxicology|January 13, 2010
Mitigating permeability-mediated risks in drug discoveryJianling Wang, Suzanne Skolnik
Expert Opinion on Drug Metabolism & Toxicology|June 12, 2012
Probe ADME and test hypotheses: a PATH beyond clearance in vitro-in vivo correlations in early drug discoveryLeslie C Bell, Jianling Wang
Journal of Pharmaceutical Sciences|February 11, 2012
Assessment of biliary clearance in early drug discovery using sandwich-cultured hepatocyte modelGuoyu Pan, Carri Boiselle, Jianling Wang
Journal of Cellular Biochemistry|March 16, 2019
miR-4458 regulates cell proliferation and apoptosis through targeting SOCS1 in triple-negative breast cancerXiaomeng Liu, Jianling Wang, Guochao Zhang
Pageof 16